Preformed Line Products (PLPC) Financials

$366.09 +7.43 (+2.07%)

Closing price 05/6/2026 04:00 PM Eastern

Extended Trading

$365.90 -0.19 (-0.05%)

As of 06:12 AM Eastern

Annual Income Statements for Preformed Line Products

This table shows Preformed Line Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	6.68	15	13	27	23	30	36	54	63	37	35
Consolidated Net Income / (Loss)	6.68	15	13	27	23	30	36	54	63	37	35
Net Income / (Loss) Continuing Operations	6.68	15	13	27	23	30	36	54	63	37	35
Total Pre-Tax Income	12	21	26	33	31	41	49	74	82	51	46
Total Operating Income	12	21	26	33	33	40	48	69	84	51	55
Total Gross Profit	103	109	119	132	141	154	166	215	235	190	209
Total Revenue	355	337	378	421	445	466	517	637	670	594	669
Operating Revenue	355	337	378	421	445	466	517	637	670	594	669
Total Cost of Revenue	251	227	260	289	304	312	351	422	435	404	461
Operating Cost of Revenue	251	227	260	289	304	312	351	422	435	404	461
Total Operating Expenses	91	88	93	99	108	114	119	146	151	139	153
Selling, General & Admin Expense	37	42	43	45	52	56	55	70	75	67	75
Marketing Expense	31	32	34	36	37	36	41	46	51	49	52
Research & Development Expense	15	14	14	15	17	18	19	20	22	22	24
Other Operating Expenses / (Income)	8.75	0.05	0.99	2.43	2.37	4.21	3.71	3.60	2.49	0.93	2.53
Total Other Income / (Expense), net	-0.64	-0.53	-0.30	-0.35	-1.17	0.36	1.35	4.34	-1.81	0.01	-9.52
Interest Expense	0.57	0.84	1.06	1.29	2.22	2.40	2.02	3.21	3.91	2.22	1.30
Interest & Investment Income	0.39	0.29	0.43	0.49	0.78	0.26	0.17	0.63	1.81	2.57	2.32
Other Income / (Expense), net	-0.47	0.03	0.33	0.46	0.27	2.50	3.20	6.93	0.28	-0.34	-11
Income Tax Expense	5.03	5.70	13	6.01	8.12	11	13	19	19	14	10
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	0.00	0.00	0.03	-0.04	-0.01	0.00	0.01	0.02	0.02
Basic Earnings per Share	$1.25	$2.95	$2.48	-	$4.63	$6.05	$7.28	$11.03	$12.87	$7.56	$7.17
Weighted Average Basic Shares Outstanding	5.35M	5.17M	5.10M	5.03M	5.03M	4.92M	4.91M	4.93M	4.92M	4.91M	4.92M
Diluted Earnings per Share	$1.24	$2.95	$2.47	-	$4.58	$5.98	$7.19	$10.88	$12.68	$7.50	$7.14
Weighted Average Diluted Shares Outstanding	5.37M	5.18M	5.13M	5.11M	5.09M	4.98M	4.97M	5.00M	5.00M	4.95M	4.94M
Weighted Average Basic & Diluted Shares Outstanding	5.30M	5.20M	5.10M	5M	5.02M	4.93M	4.91M	4.92M	4.90M	4.94M	4.90M
Cash Dividends to Common per Share	$0.80	$0.80	$0.80	$0.80	-	-	-	$0.80	$0.80	$0.80	$0.81

This table shows Preformed Line Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	15	6.33	9.60	9.37	7.68	10	12	13	2.63	8.44	11
Consolidated Net Income / (Loss)	15	6.31	9.60	9.37	7.70	10	12	13	2.62	8.44	11
Net Income / (Loss) Continuing Operations	15	6.31	9.60	9.37	7.70	10	12	13	2.62	8.44	11
Total Pre-Tax Income	20	6.97	12	11	10	17	14	17	2.36	12	14
Total Operating Income	20	6.95	12	11	10	18	13	17	13	12	14
Total Gross Profit	54	48	44	44	46	56	49	55	53	52	55
Total Revenue	160	146	141	139	147	167	149	170	178	173	176
Operating Revenue	160	146	141	139	147	167	149	170	178	173	176
Total Cost of Revenue	106	98	97	94	101	111	100	114	125	121	121
Operating Cost of Revenue	106	98	97	94	101	111	100	114	125	121	121
Total Operating Expenses	34	41	33	33	35	38	36	38	40	40	42
Selling, General & Admin Expense	18	20	17	15	16	19	18	19	19	20	21
Marketing Expense	13	13	12	12	12	13	12	13	13	13	14
Research & Development Expense	5.84	5.69	5.43	5.36	5.55	5.59	5.48	5.70	6.18	6.33	6.74
Other Operating Expenses / (Income)	-2.31	2.50	-1.37	0.45	1.11	0.75	0.26	0.82	1.13	0.32	-0.05
Total Other Income / (Expense), net	-0.50	0.02	0.30	-0.13	0.04	-0.19	0.54	0.18	-11	0.54	0.61
Interest Expense	1.00	0.71	0.71	0.57	0.56	0.38	0.38	0.32	0.31	0.30	0.23
Interest & Investment Income	0.48	0.61	0.97	0.35	0.54	0.72	0.51	0.38	0.68	0.74	0.78
Other Income / (Expense), net	0.02	0.12	0.04	0.09	0.06	-0.53	0.41	0.12	-11	0.10	0.07
Income Tax Expense	4.43	0.66	2.26	1.79	2.73	6.88	2.12	4.61	-0.26	3.85	3.78
Net Income / (Loss) Attributable to Noncontrolling Interest	0.02	-0.02	0.01	0.00	0.02	-0.01	0.04	-0.01	-0.01	-	0.03
Basic Earnings per Share	$3.08	$1.32	$1.95	$1.91	$1.57	$2.13	$2.34	$2.58	$0.53	$1.72	$2.15
Weighted Average Basic Shares Outstanding	4.91M	4.92M	4.92M	4.92M	4.90M	4.91M	4.93M	4.93M	4.92M	4.92M	4.91M
Diluted Earnings per Share	$3.03	$1.29	$1.94	$1.89	$1.54	$2.13	$2.33	$2.56	$0.53	$1.72	$2.14
Weighted Average Diluted Shares Outstanding	4.99M	5.00M	4.94M	4.96M	4.98M	4.95M	4.95M	4.96M	4.94M	4.94M	4.93M
Weighted Average Basic & Diluted Shares Outstanding	4.89M	4.90M	4.92M	4.91M	4.90M	4.94M	4.94M	4.92M	4.90M	4.90M	4.89M
Cash Dividends to Common per Share	$0.20	-	$0.20	$0.20	$0.20	-	$0.20	$0.20	$0.20	-	$0.21

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	0.75	0.35	12	-0.10	-4.65	5.91	-8.77	0.83	16	3.64	26
Net Cash From Operating Activities	20	26	34	23	27	42	34	26	108	67	73
Net Cash From Continuing Operating Activities	20	26	34	23	27	42	34	26	108	67	73
Net Income / (Loss) Continuing Operations	6.68	15	13	27	23	30	36	54	63	37	35
Consolidated Net Income / (Loss)	6.68	15	13	27	23	30	36	54	63	37	35
Depreciation Expense	12	12	13	12	14	14	16	16	19	21	23
Non-Cash Adjustments To Reconcile Net Income	4.14	6.81	5.80	7.88	8.11	9.29	11	12	14	6.12	20
Changes in Operating Assets and Liabilities, net	-2.11	-8.08	2.59	-24	-18	-11	-28	-56	11	3.42	-4.85
Net Cash From Investing Activities	-11	-28	-2.56	-14	-49	-14	-18	-47	-45	-12	-43
Net Cash From Continuing Investing Activities	-11	-28	-2.56	-14	-49	-14	-18	-47	-45	-12	-43
Purchase of Property, Plant & Equipment	-11	-25	-11	-9.53	-29	-25	-18	-41	-35	-15	-40
Acquisitions	0.00	-	0.00	0.00	-19	0.00	0.00	-16	-12	0.00	-4.75
Purchase of Investments	-	0.00	0.00	-4.69	-0.50	-	-	0.00	0.00	-3.15	-0.45
Sale of Property, Plant & Equipment	0.93	0.07	0.14	0.20	0.05	11	0.14	3.17	2.63	3.45	0.27
Sale and/or Maturity of Investments	-	0.00	0.00	2.95	2.31	-	-	0.00	0.00	1.99	1.68
Net Cash From Financing Activities	-13	4.39	-20	-9.05	18	-23	-23	23	-49	-48	-9.23
Net Cash From Continuing Financing Activities	-13	4.39	-20	-9.05	18	-23	-23	23	-49	-48	-9.23
Repayment of Debt	-53	-58	-65	-85	-64	-110	-114	-154	-197	-133	-15
Repurchase of Common Equity	-7.55	-5.07	-8.48	-4.17	-6.83	-9.46	-5.27	-5.47	-19	-8.61	-14
Payment of Dividends	-4.39	-4.17	-4.10	-4.09	-4.23	-4.18	-4.13	-4.10	-4.11	-4.08	-4.12
Issuance of Debt	52	71	56	84	93	100	99	185	169	97	22
Issuance of Common Equity	0.08	0.25	1.96	0.22	0.21	0.25	0.41	0.81	2.16	0.21	1.93
Other Net Changes in Cash	-	-1.54	-	-	-0.78	-	-0.89	-1.11	2.44	-3.68	5.29

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	0.58	9.87	-7.75	1.57	0.07	9.75	-2.41	12	6.04	10	-14
Net Cash From Operating Activities	43	19	5.75	28	9.37	24	5.66	27	19	22	6.05
Net Cash From Continuing Operating Activities	43	19	5.75	28	9.37	24	5.66	27	19	22	6.05
Net Income / (Loss) Continuing Operations	15	6.31	9.60	9.37	7.70	10	12	13	2.62	8.44	11
Consolidated Net Income / (Loss)	15	6.31	9.60	9.37	7.70	10	12	13	2.62	8.44	11
Depreciation Expense	4.64	5.31	5.41	5.25	5.32	4.85	5.40	5.69	5.81	6.14	6.17
Non-Cash Adjustments To Reconcile Net Income	0.92	6.58	-0.23	0.16	1.08	5.11	0.63	3.00	15	1.26	2.73
Changes in Operating Assets and Liabilities, net	22	1.09	-9.03	14	-4.73	3.67	-12	5.55	-4.58	6.11	-13
Net Cash From Investing Activities	-7.56	-8.09	-0.68	-3.60	-3.45	-4.63	-9.66	-13	-11	-10	-9.94
Net Cash From Continuing Investing Activities	-7.56	-8.09	-0.68	-3.60	-3.45	-4.63	-9.66	-13	-11	-10	-9.94
Purchase of Property, Plant & Equipment	-9.94	-8.21	-3.92	-3.73	-3.57	-3.43	-11	-8.38	-11	-10	-9.99
Purchase of Investments	-	-	0.00	-	-	-	-0.45	-	-	-	0.00
Sale of Property, Plant & Equipment	2.38	0.13	3.24	0.13	0.13	-0.04	0.09	0.01	0.23	-0.05	0.05
Sale and/or Maturity of Investments	-	-	0.00	-	-	-	1.68	-	-	-	0.00
Net Cash From Financing Activities	-34	-3.38	-12	-22	-7.30	-7.00	-0.02	-4.77	-2.55	-1.89	-9.96
Net Cash From Continuing Financing Activities	-34	-3.38	-12	-22	-7.30	-7.00	-0.02	-4.77	-2.55	-1.89	-9.96
Repayment of Debt	-46	-46	-38	-45	-45	-8.11	-2.74	-3.73	-5.49	-2.83	-1.43
Repurchase of Common Equity	-8.56	-0.49	-5.45	-0.57	-2.23	-0.35	-4.81	-2.35	-4.51	-2.78	-13
Payment of Dividends	-0.98	-0.98	-1.13	-0.98	-0.98	-0.98	-1.16	-0.99	-0.99	-0.98	-1.12
Issuance of Debt	21	44	33	25	41	2.39	8.63	2.21	8.20	3.17	5.00
Issuance of Common Equity	1.36	0.14	0.06	0.00	0.10	0.05	0.07	0.09	0.24	1.53	0.45
Effect of Exchange Rate Changes	-0.48	-	-	-	-	-	1.62	-	-	-	-0.08

This table presents Preformed Line Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	323	341	360	359	434	461	489	568	603	574	654
Total Current Assets	180	189	207	214	232	256	272	328	325	316	363
Restricted Cash	-	-	-	-	-	45	36	37	54	57	83
Accounts Receivable	64	63	74	73	84	93	98	125	107	111	113
Inventories, net	70	74	78	85	96	98	115	147	149	130	149
Prepaid Expenses	4.03	3.35	3.43	6.21	6.92	18	20	13	8.25	12	13
Other Current Assets	6.34	8.44	2.21	2.88	4.29	3.26	3.22	4.93	7.26	5.51	5.21
Plant, Property, & Equipment, net	92	105	109	103	124	126	150	175	208	195	223
Total Noncurrent Assets	52	47	44	42	78	79	67	65	70	63	67
Goodwill	16	16	17	16	28	30	28	28	29	27	31
Intangible Assets	11	10	10	8.46	15	14	12	14	13	9.66	10
Noncurrent Deferred & Refundable Income Taxes	13	10	7.77	6.90	7.56	11	3.84	5.32	7.11	6.55	7.48
Other Noncurrent Operating Assets	12	10	9.72	11	27	24	23	18	21	20	19
Total Liabilities & Shareholders' Equity	323	341	360	359	434	461	489	568	603	574	654
Total Liabilities	104	117	121	109	165	169	173	210	187	152	178
Total Current Liabilities	52	55	63	69	81	104	106	115	111	108	115
Short-Term Debt	0.52	2.76	2.31	10	12	23	20	21	13	10	6.61
Accounts Payable	20	22	25	26	28	32	42	47	38	42	50
Accrued Expenses	13	12	15	13	17	18	18	18	27	26	22
Dividends Payable	1.06	1.04	1.05	1.05	1.17	1.29	1.30	1.32	1.30	1.29	1.28
Current Deferred & Payable Income Tax Liabilities	1.42	1.06	1.90	0.82	1.76	5.46	1.11	2.47	1.67	1.96	3.97
Current Employee Benefit Liabilities	15	16	18	18	19	23	22	24	28	26	29
Other Current Liabilities	-	-	-	0.00	2.06	2.24	1.99	1.61	1.67	1.59	1.72
Total Noncurrent Liabilities	53	62	58	40	84	65	67	95	76	43	63
Long-Term Debt	32	43	35	25	54	33	40	68	49	18	33
Noncurrent Deferred & Payable Income Tax Liabilities	2.47	2.08	2.09	1.71	3.12	2.92	2.79	4.17	3.54	3.77	5.71
Other Noncurrent Operating Liabilities	6.87	6.50	11	8.01	22	23	21	22	23	21	25
Total Equity & Noncontrolling Interests	219	224	239	249	269	292	316	359	416	422	476
Total Preferred & Common Equity	219	224	239	249	269	292	316	359	416	422	476
Total Common Equity	219	224	239	249	269	292	316	359	416	422	476
Common Stock	35	37	42	47	52	56	61	67	75	79	81
Retained Earnings	292	303	312	334	353	379	411	461	520	553	584
Treasury Stock	-55	-60	-68	-72	-79	-89	-94	-99	-118	-127	-137
Accumulated Other Comprehensive Income / (Loss)	-54	-57	-47	-60	-57	-55	-62	-70	-60	-83	-53
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	-	-	-	0.00	0.03	-0.01	-0.02	-0.01	-0.01	0.01	0.03

This table presents Preformed Line Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	531	602	622	607	586	573	592	592	631	645	662
Total Current Assets	308	339	353	338	314	305	321	327	353	360	371
Restricted Cash	-	32	43	44	46	-	47	55	67	73	69
Accounts Receivable	123	141	145	126	112	101	111	119	124	121	131
Inventories, net	135	150	148	150	142	142	143	135	143	146	152
Prepaid Expenses	-	8.30	8.75	8.33	8.31	7.39	13	12	13	14	13
Other Current Assets	3.25	8.18	8.44	10	7.05	6.98	6.48	6.02	6.28	6.33	6.29
Plant, Property, & Equipment, net	160	196	200	201	203	200	201	203	212	218	225
Total Noncurrent Assets	63	67	68	67	69	67	70	63	66	67	65
Goodwill	26	29	30	28	29	28	29	28	30	30	30
Intangible Assets	14	14	14	13	12	11	11	9.74	9.97	9.67	9.84
Noncurrent Deferred & Refundable Income Taxes	5.90	6.15	6.42	6.93	7.38	7.72	9.50	6.28	7.20	7.31	6.79
Other Noncurrent Operating Assets	17	17	18	19	21	20	21	19	20	19	18
Total Liabilities & Shareholders' Equity	531	602	622	607	586	573	592	592	631	645	662
Total Liabilities	200	222	223	207	173	156	163	157	171	178	188
Total Current Liabilities	120	125	127	136	100	104	114	106	115	116	124
Short-Term Debt	21	17	21	18	8.57	9.75	11	9.22	8.34	7.51	7.21
Accounts Payable	48	56	50	51	42	43	42	45	51	49	57
Accrued Expenses	18	19	23	27	21	23	26	27	26	24	30
Dividends Payable	1.28	1.19	1.23	1.26	1.19	1.22	1.26	1.15	1.17	1.20	1.18
Current Deferred & Payable Income Tax Liabilities	2.36	7.80	5.79	6.76	2.36	1.53	2.35	1.15	1.17	1.90	3.17
Current Employee Benefit Liabilities	28	22	25	30	23	24	29	21	26	31	24
Other Current Liabilities	1.64	1.54	1.19	1.63	1.53	1.56	1.61	1.75	1.80	1.80	1.55
Total Noncurrent Liabilities	79	96	97	71	73	52	49	51	56	62	65
Long-Term Debt	56	68	69	45	48	29	25	26	28	31	35
Capital Lease Obligations	6.33	7.11	-	7.91	7.39	-	6.99	6.46	-	6.18	5.51
Noncurrent Deferred & Payable Income Tax Liabilities	3.86	3.51	3.31	2.98	3.41	2.21	2.84	3.02	3.50	5.66	5.46
Other Noncurrent Operating Liabilities	13	17	24	15	14	21	15	16	25	19	19
Total Equity & Noncontrolling Interests	331	381	398	400	413	416	429	436	461	466	474
Total Preferred & Common Equity	331	381	398	400	413	416	429	436	461	466	474
Total Common Equity	331	381	398	400	413	416	429	436	461	466	474
Common Stock	65	68	70	73	75	76	77	76	78	79	80
Retained Earnings	445	481	501	515	529	537	544	564	575	577	594
Treasury Stock	-98	-103	-109	-118	-124	-124	-127	-128	-130	-135	-145
Accumulated Other Comprehensive Income / (Loss)	-82	-66	-64	-70	-67	-73	-65	-76	-62	-55	-55
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	0.01	0.01	0.00	0.02	-0.00	0.00	0.02	0.05	0.04	0.03	0.06

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	4,901,871.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	4,901,871.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	7.20
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	7.04	16	13	27	24	29	35	51	65	37	43
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	11.42%	13.53%	8.23%	8.29%
Earnings before Interest and Taxes (EBIT)	12	22	26	33	33	43	51	76	84	50	45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	23	34	39	46	47	57	66	93	103	71	68
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	33	-1.99	20	17	-30	22	-1.68	-20	51	68	4.71
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	222	240	232	242	297	304	341	412	426	395	433
Increase / (Decrease) in Invested Capital	-26	18	-7.41	10	54	7.58	36	72	14	-31	38
Book Value per Share	$41.54	$43.66	$46.85	$49.75	$53.62	$59.43	$64.51	$72.90	$85.04	$86.23	$97.01
Tangible Book Value per Share	$36.39	$38.53	$41.63	$44.95	$45.04	$50.49	$56.30	$64.34	$76.36	$78.81	$88.68
Total Capital	251	269	275	285	334	348	376	448	478	451	515
Total Debt	32	46	37	35	66	56	60	90	62	29	39
Total Long-Term Debt	32	43	35	25	54	33	40	68	49	18	33
Net Debt	1.88	15	-7.45	-8.16	27	11	23	52	8.64	-29	-44
Capital Expenditures (CapEx)	9.83	25	11	9.33	29	14	18	37	33	11	40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	98	106	102	112	124	130	150	197	173	160	172
Debt-free Net Working Capital (DFNWC)	129	136	147	155	163	175	186	234	227	218	255
Net Working Capital (NWC)	128	134	144	145	151	153	167	213	213	207	249
Net Nonoperating Expense (NNE)	0.37	0.38	0.15	0.28	0.87	-0.27	-0.98	-3.21	1.39	-0.01	7.36
Net Nonoperating Obligations (NNO)	2.94	16	-6.40	-7.11	28	12	24	54	9.94	-27	-43
Total Depreciation and Amortization (D&A)	12	12	13	12	14	14	16	16	19	21	23
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.25	$2.95	$2.48	$5.28	$4.63	$0.00	$7.28	$11.03	$12.87	$7.56	$7.17
Adjusted Weighted Average Basic Shares Outstanding	5.35M	5.17M	5.10M	5.03M	5.03M	4.92M	4.91M	4.93M	4.92M	4.91M	4.92M
Adjusted Diluted Earnings per Share	$1.24	$2.95	$2.47	$5.21	$4.58	$0.00	$7.19	$10.88	$12.68	$7.50	$7.14
Adjusted Weighted Average Diluted Shares Outstanding	5.37M	5.18M	5.13M	5.11M	5.09M	4.98M	4.97M	5.00M	5.00M	4.95M	4.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	5.21M	5.12M	5.04M	5.06M	5.02M	4.93M	4.91M	4.92M	4.90M	4.94M	4.90M
Normalized Net Operating Profit after Tax (NOPAT)	7.04	16	18	27	24	29	35	56	65	37	43
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	4,901,871.00	4,896,855.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	4,901,871.00	4,896,855.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	1.72	2.15
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.00%	-14.31%	-22.51%	-23.70%	-8.39%	14.78%	5.42%	22.26%	21.17%	-	18.67%
EBITDA Growth	14.58%	-60.41%	-48.92%	-49.53%	-36.21%	76.40%	11.32%	37.87%	-50.62%	-	5.37%
EBIT Growth	9.98%	-71.76%	-60.05%	-59.71%	-47.97%	140.41%	16.76%	51.45%	-81.02%	-	1.83%
NOPAT Growth	32.32%	-62.45%	-57.39%	-54.69%	-50.64%	67.91%	18.53%	32.60%	90.38%	-	-9.00%
Net Income Growth	27.39%	-61.74%	-55.17%	-54.23%	-49.18%	65.56%	20.31%	35.58%	-65.97%	-	-8.69%
EPS Growth	28.39%	-60.43%	-54.67%	-53.68%	-49.17%	65.12%	20.10%	35.45%	-65.58%	-	-8.15%
Operating Cash Flow Growth	177.82%	13.25%	-77.38%	38.56%	-77.96%	24.78%	-1.70%	-4.83%	102.22%	-	6.93%
Free Cash Flow Firm Growth	26.69%	86.21%	149.08%	207.32%	138.86%	651.10%	4.88%	-121.53%	-100.75%	-	-194.99%
Invested Capital Growth	11.28%	3.36%	-2.23%	-8.40%	-0.74%	-7.31%	-2.10%	5.55%	3.45%	-	6.91%
Revenue Q/Q Growth	-11.76%	-9.25%	-3.23%	-1.55%	5.95%	13.71%	-11.12%	14.18%	5.00%	-	1.83%
EBITDA Q/Q Growth	-24.92%	-49.96%	37.42%	-2.23%	-5.12%	38.38%	-13.28%	21.08%	-66.02%	-	10.93%
EBIT Q/Q Growth	-28.88%	-64.84%	64.10%	-1.82%	-8.14%	62.44%	-20.30%	27.35%	-88.49%	-	16.39%
NOPAT Q/Q Growth	-25.73%	-59.51%	48.82%	1.24%	-19.09%	37.73%	5.06%	13.25%	16.17%	-	25.19%
Net Income Q/Q Growth	-25.99%	-58.34%	52.21%	-2.46%	-17.84%	35.72%	10.61%	9.93%	-79.38%	-	25.06%
EPS Q/Q Growth	-25.74%	-57.43%	50.39%	-2.58%	-18.52%	38.31%	9.39%	9.87%	-79.30%	-	24.42%
Operating Cash Flow Q/Q Growth	108.15%	-54.62%	-70.17%	391.81%	-66.90%	156.96%	-76.50%	376.18%	-29.66%	-	-72.44%
Free Cash Flow Firm Q/Q Growth	36.30%	72.83%	354.24%	143.90%	-76.93%	285.32%	-51.61%	-150.07%	99.20%	-	35.86%
Invested Capital Q/Q Growth	-4.02%	-0.47%	1.52%	-5.55%	4.00%	-7.06%	7.23%	1.83%	1.94%	-	4.59%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.74%	33.04%	31.32%	31.92%	31.15%	33.29%	32.77%	32.66%	29.68%	-	31.33%
EBITDA Margin	15.42%	8.50%	12.07%	11.99%	10.74%	13.06%	12.75%	13.52%	4.37%	-	11.32%
Operating Margin	12.51%	4.77%	8.20%	8.14%	7.07%	10.48%	8.84%	10.10%	7.37%	-	7.78%
EBIT Margin	12.53%	4.85%	8.23%	8.21%	7.11%	10.16%	9.11%	10.17%	1.11%	-	7.82%
Profit (Net Income) Margin	9.44%	4.33%	6.82%	6.75%	5.24%	6.25%	7.78%	7.49%	1.47%	-	5.98%
Tax Burden Percent	77.37%	90.54%	80.98%	83.93%	73.79%	60.30%	84.51%	73.39%	111.16%	-	73.61%
Interest Burden Percent	97.41%	98.63%	102.28%	98.05%	99.75%	101.98%	100.99%	100.38%	118.69%	-	103.95%
Effective Tax Rate	22.63%	9.46%	19.02%	16.07%	26.21%	39.70%	15.49%	26.62%	-11.16%	-	26.39%
Return on Invested Capital (ROIC)	16.53%	6.90%	9.55%	9.36%	7.00%	9.14%	10.49%	11.16%	12.58%	-	9.11%
ROIC Less NNEP Spread (ROIC-NNEP)	15.59%	6.96%	10.15%	8.81%	7.23%	10.47%	23.78%	10.44%	90.47%	-	6.39%
Return on Net Nonoperating Assets (RNNOA)	1.75%	0.57%	1.03%	0.43%	0.21%	-0.22%	0.19%	-0.44%	-3.11%	-	-0.23%
Return on Equity (ROE)	18.28%	7.47%	10.58%	9.80%	7.21%	8.92%	10.69%	10.71%	9.47%	-	8.88%
Cash Return on Invested Capital (CROIC)	7.81%	12.14%	14.18%	18.29%	8.43%	16.63%	11.21%	4.60%	6.98%	-	2.75%
Operating Return on Assets (OROA)	15.29%	5.55%	8.71%	8.05%	6.79%	10.25%	9.30%	10.68%	1.20%	-	8.69%
Return on Assets (ROA)	11.52%	4.95%	7.21%	6.62%	5.00%	6.31%	7.94%	7.86%	1.58%	-	6.65%
Return on Common Equity (ROCE)	18.28%	7.47%	10.58%	9.80%	7.21%	8.92%	10.69%	10.71%	9.47%	-	8.88%
Return on Equity Simple (ROE_SIMPLE)	18.39%	0.00%	12.46%	9.71%	7.69%	0.00%	8.96%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	16	6.29	9.36	9.48	7.67	11	11	13	15	8.07	10
NOPAT Margin	9.68%	4.32%	6.64%	6.83%	5.22%	6.32%	7.47%	7.41%	8.20%	-	5.73%
Net Nonoperating Expense Percent (NNEP)	0.95%	-0.06%	-0.60%	0.55%	-0.23%	-1.33%	-13.28%	0.72%	-77.89%	-	2.73%
Return On Investment Capital (ROIC_SIMPLE)	-	1.31%	-	-	-	2.34%	2.33%	2.53%	2.85%	1.57%	1.94%
Cost of Revenue to Revenue	66.26%	66.96%	68.68%	68.08%	68.85%	66.71%	67.23%	67.34%	70.32%	-	68.67%
SG&A Expenses to Revenue	11.09%	13.75%	11.79%	10.99%	11.17%	11.49%	11.87%	11.01%	10.75%	-	11.94%
R&D to Revenue	3.64%	3.91%	3.85%	3.86%	3.77%	3.34%	3.69%	3.36%	3.47%	-	3.82%
Operating Expenses to Revenue	21.23%	28.26%	23.12%	23.78%	24.08%	22.81%	23.93%	22.57%	22.30%	-	23.54%
Earnings before Interest and Taxes (EBIT)	20	7.07	12	11	10	17	14	17	1.99	12	14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	25	12	17	17	16	22	19	23	7.79	18	20
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.99	1.56	1.52	1.47	1.46	1.48	1.59	1.71	2.07	-	2.80
Price to Tangible Book Value (P/TBV)	2.21	1.74	1.69	1.62	1.61	1.62	1.74	1.87	2.26	-	3.06
Price to Revenue (P/Rev)	1.14	0.97	1.00	1.04	1.10	1.05	1.15	1.25	1.45	-	1.90
Price to Earnings (P/E)	10.80	10.26	12.21	15.13	19.06	16.85	17.72	18.62	25.87	-	38.64
Dividend Yield	0.50%	0.60%	0.62%	0.64%	0.63%	0.63%	0.57%	0.50%	0.41%	-	0.30%
Earnings Yield	9.26%	9.74%	8.19%	6.61%	5.25%	5.94%	5.64%	5.37%	3.87%	-	2.59%
Enterprise Value to Invested Capital (EV/IC)	1.92	1.55	1.50	1.48	1.47	1.51	1.60	1.76	2.13	-	2.88
Enterprise Value to Revenue (EV/Rev)	1.18	0.98	1.03	1.03	1.09	1.00	1.13	1.20	1.41	-	1.87
Enterprise Value to EBITDA (EV/EBITDA)	6.72	6.37	7.43	8.52	10.08	8.37	9.26	9.54	13.11	-	18.98
Enterprise Value to EBIT (EV/EBIT)	8.02	7.80	9.66	12.02	15.39	11.83	12.94	13.02	18.84	-	29.05
Enterprise Value to NOPAT (EV/NOPAT)	10.93	10.17	12.41	14.81	19.00	16.07	17.44	18.05	20.89	-	31.55
Enterprise Value to Operating Cash Flow (EV/OCF)	7.79	6.12	7.36	6.29	9.94	8.84	10.06	11.48	12.40	-	17.64
Enterprise Value to Free Cash Flow (EV/FCFF)	25.86	12.95	10.43	7.71	17.33	8.73	14.13	39.25	31.05	-	108.30
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.18	0.15	0.15	0.09	0.10	0.07	0.09	0.08	0.10	-	0.10
Long-Term Debt to Equity	0.13	0.12	0.13	0.07	0.07	0.04	0.07	0.06	0.08	-	0.09
Financial Leverage	0.11	0.08	0.10	0.05	0.03	-0.02	0.01	-0.04	-0.03	-	-0.04
Leverage Ratio	1.56	1.51	1.50	1.47	1.45	1.40	1.39	1.37	1.38	-	1.38
Compound Leverage Factor	1.52	1.49	1.53	1.44	1.44	1.43	1.40	1.38	1.64	-	1.43
Debt to Total Capital	15.03%	13.01%	13.39%	8.48%	8.96%	6.34%	8.67%	7.29%	8.81%	-	9.11%
Short-Term Debt to Total Capital	3.73%	2.81%	1.79%	2.14%	2.25%	2.26%	1.93%	1.68%	1.47%	-	1.38%
Long-Term Debt to Total Capital	11.30%	10.20%	11.59%	6.34%	6.70%	4.07%	6.73%	5.61%	7.34%	-	7.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	-	0.01%
Common Equity to Total Capital	84.96%	86.99%	86.61%	91.52%	91.04%	93.66%	91.32%	92.70%	91.19%	-	90.88%
Debt to EBITDA	0.58	0.60	0.73	0.55	0.68	0.40	0.57	0.46	0.63	-	0.69
Net Debt to EBITDA	0.22	0.08	0.21	-0.13	-0.09	-0.40	-0.18	-0.39	-0.39	-	-0.32
Long-Term Debt to EBITDA	0.44	0.47	0.64	0.41	0.51	0.26	0.44	0.35	0.53	-	0.59
Debt to NOPAT	0.94	0.96	1.23	0.95	1.29	0.77	1.06	0.86	1.00	-	1.15
Net Debt to NOPAT	0.36	0.13	0.35	-0.22	-0.16	-0.77	-0.35	-0.73	-0.62	-	-0.53
Long-Term Debt to NOPAT	0.71	0.75	1.06	0.71	0.96	0.49	0.83	0.66	0.84	-	0.97
Altman Z-Score	5.15	4.87	5.03	5.17	5.04	5.39	5.52	5.59	5.99	-	7.05
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.01%	-	0.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.49	2.92	3.15	2.93	2.81	2.91	3.08	3.08	3.09	-	3.01
Quick Ratio	0.93	0.96	1.12	1.43	0.97	1.03	1.12	1.08	1.04	-	1.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-28	-7.57	19	47	11	42	20	-10	-0.08	-30	-19
Operating Cash Flow to CapEx	561.92%	238.45%	844.79%	785.94%	271.79%	693.57%	51.95%	321.64%	182.19%	-	60.81%
Free Cash Flow to Firm to Interest Expense	-27.92	-10.71	27.18	82.64	19.20	109.50	53.69	-31.78	-0.26	-	-82.65
Operating Cash Flow to Interest Expense	42.59	27.28	8.13	49.81	16.61	63.17	15.04	84.68	60.71	-	26.06
Operating Cash Flow Less CapEx to Interest Expense	35.01	15.84	7.16	43.48	10.50	54.06	-13.91	58.35	27.38	-	-16.80
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.22	1.14	1.06	0.98	0.95	1.01	1.02	1.05	1.07	-	1.11
Accounts Receivable Turnover	5.58	5.77	4.98	4.76	4.83	5.44	5.23	5.61	5.73	-	5.59
Inventory Turnover	3.13	2.94	2.86	2.72	2.67	2.90	2.94	2.99	3.12	-	3.36
Fixed Asset Turnover	3.85	3.50	3.15	2.92	2.84	2.95	2.96	3.07	3.17	-	3.25
Accounts Payable Turnover	8.94	10.28	8.49	8.50	8.31	10.13	9.36	9.07	9.88	-	9.45
Days Sales Outstanding (DSO)	65.47	63.27	73.33	76.67	75.56	67.10	69.81	65.05	63.74	-	65.28
Days Inventory Outstanding (DIO)	116.56	124.35	127.77	134.11	136.84	125.94	124.03	121.96	116.92	-	108.64
Days Payable Outstanding (DPO)	40.83	35.52	43.00	42.96	43.94	36.03	39.01	40.23	36.96	-	38.63
Cash Conversion Cycle (CCC)	141.19	152.09	158.11	167.83	168.46	157.01	154.83	146.77	143.71	-	135.29
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	428	426	433	409	425	395	423	431	440	433	453
Invested Capital Turnover	1.71	1.60	1.44	1.37	1.34	1.45	1.40	1.51	1.53	-	1.59
Increase / (Decrease) in Invested Capital	43	14	-9.89	-37	-3.16	-31	-9.09	23	15	38	29
Enterprise Value (EV)	821	659	647	603	623	596	678	758	937	-	1,303
Market Capitalization	794	650	629	612	628	625	691	789	965	-	1,325
Book Value per Share	$81.34	$85.04	$84.29	$84.63	$87.30	$86.23	$88.20	$93.26	$94.68	$97.01	$96.70
Tangible Book Value per Share	$72.96	$76.36	$76.04	$76.71	$79.23	$78.81	$80.61	$85.27	$86.53	$88.68	$88.49
Total Capital	471	478	477	455	471	451	477	497	511	515	521
Total Debt	71	62	64	39	42	29	41	36	45	39	47
Total Long-Term Debt	53	49	55	29	32	18	32	28	38	33	40
Net Debt	27	8.64	18	-8.85	-5.30	-29	-13	-31	-28	-44	-22
Capital Expenditures (CapEx)	7.56	8.09	0.68	3.60	3.45	3.47	11	8.37	10	10	9.94
Debt-free, Cash-free Net Working Capital (DFCFNWC)	176	173	177	163	170	160	175	180	178	172	186
Debt-free Net Working Capital (DFNWC)	220	227	223	211	217	218	230	247	251	255	255
Net Working Capital (NWC)	202	213	215	201	207	207	221	238	244	249	248
Net Nonoperating Expense (NNE)	0.39	-0.02	-0.24	0.11	-0.03	0.12	-0.46	-0.13	12	-0.37	-0.45
Net Nonoperating Obligations (NNO)	28	9.94	19	-7.63	-4.04	-27	-12	-30	-27	-43	-21
Total Depreciation and Amortization (D&A)	4.64	5.31	5.41	5.25	5.32	4.85	5.40	5.69	5.81	6.14	6.17
Debt-free, Cash-free Net Working Capital to Revenue	25.39%	25.88%	28.19%	27.90%	29.67%	27.01%	29.13%	28.44%	26.89%	-	26.62%
Debt-free Net Working Capital to Revenue	31.69%	33.89%	35.49%	36.00%	37.97%	36.65%	38.25%	39.03%	37.89%	-	36.58%
Net Working Capital to Revenue	29.16%	31.88%	34.12%	34.34%	36.11%	34.93%	36.72%	37.71%	36.76%	-	35.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.08	$1.32	$1.95	$1.91	$1.57	$2.13	$2.34	$2.58	$0.53	$1.72	$2.15
Adjusted Weighted Average Basic Shares Outstanding	4.91M	4.92M	4.92M	4.92M	4.90M	4.91M	4.93M	4.93M	4.92M	4.92M	4.91M
Adjusted Diluted Earnings per Share	$3.03	$1.29	$1.94	$1.89	$1.54	$2.13	$2.33	$2.56	$0.53	$1.72	$2.14
Adjusted Weighted Average Diluted Shares Outstanding	4.99M	5.00M	4.94M	4.96M	4.98M	4.95M	4.95M	4.96M	4.94M	4.94M	4.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.89M	4.90M	4.92M	4.91M	4.90M	4.94M	4.94M	4.92M	4.90M	4.90M	4.89M
Normalized Net Operating Profit after Tax (NOPAT)	16	6.29	9.36	9.48	7.67	11	11	13	9.19	8.07	10
Normalized NOPAT Margin	9.68%	4.32%	6.64%	6.83%	5.22%	6.32%	7.47%	7.41%	5.16%	-	5.73%
Pre Tax Income Margin	12.20%	4.79%	8.42%	8.05%	7.10%	10.36%	9.20%	10.20%	1.32%	-	8.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	20.14	9.99	16.38	20.04	18.54	44.58	36.00	54.21	6.36	-	59.42
NOPAT to Interest Expense	15.56	8.90	13.22	16.68	13.60	27.72	29.51	39.52	46.79	-	43.52
EBIT Less CapEx to Interest Expense	12.56	-1.45	15.41	13.70	12.43	35.47	7.05	27.89	-26.96	-	16.56
NOPAT Less CapEx to Interest Expense	7.99	-2.54	12.26	10.35	7.49	18.61	0.56	13.19	13.47	-	0.66
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	5.63%	6.48%	7.92%	10.09%	12.36%	10.98%	10.52%	9.70%	11.03%	-	11.86%
Augmented Payout Ratio	32.74%	36.31%	47.91%	47.37%	38.89%	34.17%	30.91%	32.69%	43.26%	-	77.52%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Preformed Line Products (PLPC) quarterly statements over the last four years, focusing on cash flow, income, and balance-sheet trends. The bullets below are ordered with positives first, then neutral items, then negatives.

Solid revenue base with upward Q4 2025 year-over-year growth. Quarterly revenue hovered in the $160–180 million range, with Q4 2025 revenue of $173.1 million, up from Q4 2024’s $167.1 million.
Consistent positive operating cash flow. Net cash from continuing operating activities was $21.94 million in Q4 2025 and $26.93 million in Q2 2025, highlighting strong cash generation from core operations.
Positive free cash flow in several quarters. Free cash flow was healthy in recent periods (roughly $11.8 million in Q4 2025 after capex around $10.2 million), supporting debt service and capital needs.
Healthy liquidity position as of mid-2025. At Q3 2025, current assets were about $360.3 million vs. current liabilities of $116.4 million, yielding a rough current ratio near 3.1 and a comfortable liquidity cushion.
Positive earnings per share in multiple quarters and a positive net income trend. Net income from continuing operations was positive in Q1–Q4 2025 (e.g., about $11.6–12.8 million in Q1–Q2, $2.6 million in Q3, and $8.4 million in Q4), contributing to constructive EPS in several periods (Q1 2025 basic EPS around $2.58; Q4 2025 basic EPS $1.72).
Margin and profitability variability. Gross margin fluctuates across quarters (about 29.8% in Q4 2025 vs. around mid-30s in some 2024 periods). This suggests some mix or pricing shifts impacting margins on a quarterly basis.
Debt levels modestly rising but still manageable. Long-term debt has trended upward (approximately $25–31 million across recent quarters), while interest expense remains relatively low, indicating manageable leverage for now.
Capex levels indicate ongoing investment in capacity. Purchases of property, plant & equipment run in the roughly $8–11 million per quarter range, which supports capacity but reduces near-term free cash flow.
Quarterly profit volatility in 2025 (notably Q3 dip). Net income fluctuated, with Q3 2025 showing significantly lower earnings (~$2.6 million) than Q2 2025 (~$12.7 million), underscoring quarterly volatility in drivers like operating expenses and other income/expense items.
Rising liabilities and leverage pressures. Total liabilities rose into the mid-to-high $170 million range by mid-2025, and long-term debt increased, contributing to a higher baseline leverage profile going forward.

05/07/26 03:46 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Preformed Line Products' Financials

When does Preformed Line Products' fiscal year end?

According to the most recent income statement we have on file, Preformed Line Products' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Preformed Line Products' net income changed over the last 10 years?

Preformed Line Products' net income appears to be on an upward trend, with a most recent value of $35.31 million in 2025, rising from $6.68 million in 2015. The previous period was $37.11 million in 2024. Find out what analysts predict for Preformed Line Products in the coming months.

What is Preformed Line Products' operating income?

Preformed Line Products' total operating income in 2025 was $55.14 million, based on the following breakdown:

Total Gross Profit: $208.54 million
Total Operating Expenses: $153.40 million

How has Preformed Line Products' revenue changed over the last 10 years?

Over the last 10 years, Preformed Line Products' total revenue changed from $354.67 million in 2015 to $669.34 million in 2025, a change of 88.7%.

How much debt does Preformed Line Products have?

Preformed Line Products' total liabilities were at $178.07 million at the end of 2025, a 17.5% increase from 2024, and a 70.6% increase since 2015.

How has Preformed Line Products' book value per share changed over the last 10 years?

Over the last 10 years, Preformed Line Products' book value per share changed from 41.54 in 2015 to 97.01 in 2025, a change of 133.5%.

Related Companies

Financial statements for NASDAQ:PLPC last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Preformed Line Products (PLPC) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Preformed Line Products' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Preformed Line Products (PLPC) Financials

Annual Income Statements for Preformed Line Products

Quarterly Income Statements for Preformed Line Products

Annual Cash Flow Statements for Preformed Line Products

Quarterly Cash Flow Statements for Preformed Line Products

Annual Balance Sheets for Preformed Line Products

Quarterly Balance Sheets for Preformed Line Products

Annual Metrics And Ratios for Preformed Line Products

Quarterly Metrics And Ratios for Preformed Line Products

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Preformed Line Products' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools